drugset / Trial / NCT00605137

Safety of Insulin Detemir in Children With Type 1 Diabetes

NCT00605137

Phase 3 Completed 83 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Japan. The aim of trial is to investigate the safety of insulin detemir and insulin NPH in children with type 1 diabetes.

Timeline

Start
2004-05-21
Primary completion
2005-04-23
Completion
2005-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic